Profilo
Attualmente, Philip Roberts occupa la posizione di vicepresidente senior delle operazioni tecniche presso Mirati Therapeutics, Inc.
Precedenti posizioni note di Philip Roberts
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOME, INC. | Chief Tech/Sci/R&D Officer | 01/01/2024 |
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 01/11/2022 |
Formazione di Philip Roberts
| Louisiana State University | Graduate Degree |
| Rensselaer Polytechnic Institute | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Philip Roberts
